Albemarle Earnings Call: Cash Strength Amid Lithium Cycles

Albemarle Corporation ((ALB)) has held its Q4 earnings call. Read on for the main highlights of the call.

Albemarle Corporation’s latest earnings call struck a cautiously optimistic tone, emphasizing strong operational execution and cash generation despite accounting losses and some margin pressure. Management highlighted robust Energy Storage growth, sizeable cost savings, and improving liquidity, while acknowledging exposure to lithium price swings, foreign exchange headwinds, and softer performance in certain specialty businesses.

Q4 Revenue Momentum and Volume Growth

Albemarle posted fourth-quarter net sales of $1.40 billion, up 16% year over year, driven by broad-based volume gains across its portfolio. Energy Storage volumes climbed 17% and Ketjen volumes rose 13% in the quarter, underscoring resilient demand even as the company navigates price and currency volatility.

EBITDA Improvement and Energy Storage Outperformance

Adjusted EBITDA for Q4 increased 7% to $269 million, supported by margin expansion in the lithium-centric Energy Storage segment. For the full year, Energy Storage delivered 235,000 tons of LCE volumes, with Q4 net sales up 23% and segment EBITDA up 25% as higher lithium pricing and productivity gains more than offset cost and FX pressures.

Full-Year Strength and Powerful Cash Generation

For 2025, Albemarle reported net sales of $5.1 billion and adjusted EBITDA of $1.1 billion, translating into strong profitability in a still-evolving lithium market. The company converted this into nearly $700 million of positive free cash flow and an impressive 117% EBITDA-to-operating-cash conversion, well above its long-term 60%–70% target range after adjusting for one-off items.

Cost-Out Wins and Tight Capital Spending

Management underscored its efficiency drive, citing roughly $450 million of run-rate cost and productivity improvements achieved in 2025. Capital expenditures were cut by about 65% year over year, and Albemarle aims to squeeze out an additional $100 million to $150 million of savings in 2026 while keeping CapEx broadly flat to protect balance sheet strength.

Portfolio Moves Bolster Liquidity and Flexibility

Albemarle is reshaping its portfolio to free up capital and focus on core lithium assets, closing the sale of its Eurecat stake in January 2026 and expecting to sell a majority stake in Ketjen in the first quarter. The combined pretax proceeds of about $660 million are set to enhance financial flexibility, support deleveraging, and fund targeted corporate priorities.

Upgraded Lithium Demand Outlook

In a key positive for long-term investors, the company raised its global lithium demand forecast, now seeing 2026 demand at 1.8 million to 2.2 million tons, implying 15% to 40% year-on-year growth. Looking further out, Albemarle lifted its 2030 demand estimate by roughly 10% to 2.8 million to 3.6 million tons, driven by robust stationary storage and continued electric vehicle adoption.

Operational Steps to Protect Margins

To improve profitability, Albemarle decided to idle Kemerton Train 1, a move expected to be accretive to adjusted EBITDA from the second quarter of 2026 without reducing sales volumes. The company plans to cover hydroxide demand from other plants or tolling arrangements, maintaining optionality to restart the asset when economics justify it.

Ketjen Turnaround Continues to Deliver

Ketjen, Albemarle’s catalyst-focused business, showed clear turnaround momentum, with Q4 net sales up 14% year over year and adjusted EBITDA growing 39%. For the full year, adjusted EBITDA rose 15%, marking the third straight year of improvement under the turnaround plan and supporting the valuation of the planned majority stake sale.

GAAP Loss Driven by Noncash Charges

Despite solid operating trends, Albemarle reported a GAAP net loss of $3.87 per diluted share in the fourth quarter, weighed down by tax-related items and a noncash impairment associated with the expected Ketjen transaction. On an adjusted basis, excluding these charges, the company posted a diluted loss of $0.53 per share, highlighting how accounting hits masked underlying performance.

Margin Compression and FX Drag

Adjusted EBITDA margin slipped roughly 150 basis points year over year as unfavorable foreign exchange and weaker Specialties margins pressured profitability. Corporate results were notably affected by FX hedging losses tied to stronger Australian dollar and Chinese yuan rates, illustrating the translation risks in Albemarle’s global footprint.

Specialties Under Pressure and Lower Pricing

The Specialties segment delivered 5% year-over-year net sales growth in Q4 but saw adjusted EBITDA decline about 6% as lithium specialties margins compressed. Looking to 2026, Albemarle expects segment sales of $1.2 billion to $1.4 billion and EBITDA of $170 million to $230 million, implying mid-teens margins and year-on-year declines amid softer oil and gas and elastomer demand and lower lithium specialties pricing.

Temporary Disruption at JBC

Operations at the JBC joint venture in Jordan were temporarily disrupted by flooding, leading to an estimated revenue loss of $10 million to $15 million. The company noted that the site has since returned to full operating rates, limiting the longer-term financial impact of the incident.

Kemerton Idling Costs and Restart Economics

While the Kemerton Train 1 idling is expected to help EBITDA, it comes with about $100 million of cash costs to place the asset into care and maintenance, plus ongoing expenses to keep it restart-ready. Albemarle stressed that a restart will require meaningfully higher Western conversion pricing to close an estimated $4 to $5 per kilogram cost gap versus Chinese converters.

Working Capital and Cash Timing Frictions

Management flagged timing-related headwinds that could disconnect EBITDA from cash in 2026, including recognition of $88 million of deferred revenue tied to a 2025 customer prepayment that will not generate new cash. Rising lithium prices could also inflate working capital, which typically averages around 25% of sales, potentially dampening free cash flow despite steady earnings.

Equity Income and Inventory Effects on Volumes

Equity income, net of FX effects, fell year over year due largely to an inventory timing lag at the Greenbushes operation that had previously supported 2025 sales. Inventory drawdowns that helped performance last year now contribute to a flatter 2026 Energy Storage volume outlook, with Albemarle expecting roughly flat salts sales volumes versus 2025.

Market and Execution Risks Remain

The company acknowledged that lithium specialties pricing is adjusting downward from peak levels and highlighted that future cash generation remains highly sensitive to sustained lithium prices. Management also cautioned that an estimated 30,000 to 50,000 tons of Chinese capacity could return to the market, potentially weighing on pricing and testing Albemarle’s cost competitiveness and execution.

Guidance and Scenario-Based Outlook

Looking ahead, Albemarle framed 2026 using scenario analysis anchored on three LCE price cases of about $10, $20, and $30 per kilogram, reflecting recent and historical averages. With around 40% of salts volumes under long-term contracts, the company aims to pair its raised lithium demand outlook with disciplined costs, flat CapEx, continued portfolio proceeds, and Kemerton idling benefits to drive margins toward the low-40% and mid-50% ranges in the higher-price scenarios.

Albemarle’s earnings call painted the picture of a lithium leader tightening its belt while leaning into long-term demand growth, delivering strong cash flow today and preparing for multiple price environments. Investors will be weighing the company’s cost wins, portfolio reshaping, and bullish demand view against FX headwinds, specialty weakness, and persistent lithium price uncertainty as the cycle unfolds.